Meeting
2023 ASCO Annual Meeting
An interventional study of the impact of digital patient monitoring (DPM) on health outcomes, healthcare resource utilization, and feasibility of a combination with at-home treatment (tx) for delivery of systemic anticancer tx in clinical practice.
Authors
Sanna Iivanainen
Oulu University Hospital, Oulu, Finland
Sanna Iivanainen , Anne-Marie Baird , Bogdana Balas , Alberto Bustillos , Yovanna Castro , Manuela Eicher , Sophie Golding , Mathis Mueller-Ohldach , Maria Reig , Manfred Welslau , Johannes Ammann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Telemedicine/Remote Care
Clinical Trial Registration Number
NCT05694013
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS1617)
DOI
10.1200/JCO.2023.41.16_suppl.TPS1617
Abstract #
TPS1617
Poster Bd #
206b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP).
First Author: Bruna Pellini
Poster
2022 ASCO Annual Meeting
Monitoring PD-L1 expression on circulating stromal cells in blood predicts PFS and OS in patients with metastatic NSCLC treated with PD-L1/PD-1 immunotherapy.
First Author: Jillian Moran
Poster
2022 ASCO Annual Meeting
Monitoring engorgement of phagocytic circulating stromal cells during chemo-radiotherapy induction predicts survival in unresectable stage 2/3 NSCLC.
First Author: Kirby P Gardner
Poster
2022 ASCO Annual Meeting
Evaluating an AI-based nutrition expert platform delivered via SMS-text to support patients with cancer.
First Author: Marissa Lubin Buchan